Spherex Expands Colorado Cannabis Operations With First Acquisition
Forbes reported Spherex's first acquisition, a Colorado expansion move, but the target, price and structure weren't available in the initial signal.
High-quality close-up image of dried cannabis buds in a clear glass container, showcasing texture and detail.
What Forbes reported
Spherex made its first acquisition, and Forbes framed it as an expansion of the company's Colorado cannabis operations.
That headline is the only confirmed detail CannIntel has as of Oct. 6, 2026. The signal doesn't name the acquired company, the price, the deal structure or a closing date. Nothing more.
We won't guess at them.
What's still missing
Without the target, the price or the terms, nobody outside the deal can size it yet.
Those are the details that separate a tuck-in from a strategic bet. Four items would change the read immediately:
- What the target actually is: a license, a dispensary, a cultivation site or a software asset
- The consideration: cash, stock or an earnout
- Whether the Colorado Marijuana Enforcement Division has to sign off on the ownership change
- Whether the deal has closed or is still pending
Why a first deal matters
A first acquisition signals a pivot from building to buying, and that changes the operating burden.
Colorado opened adult-use retail sales in 2014, so it's a market where growth often means taking over someone else's licenses, customers and headaches. Buying is faster than building. It's also messier.
First deals are where a company learns what its systems can't handle. That's the real test here.
The tech stack question
Integration work after closing, not the signing, usually decides whether a cannabis acquisition pays off.
Colorado licensees run on METRC for state seed-to-sale tracking, but the layers above it vary widely. A new owner has to reconcile POS platforms, inventory feeds, payment processing and loyalty data. Each vendor contract carries its own pricing model and exit terms. If the target touches the plant, 280E belongs in the deal model from day one.
None of that is in the Forbes headline. All of it will show up in margins within a few quarters.
What to watch next
State licensing records and company disclosures will supply the details Forbes' headline leaves out.
For full background on this story, see the CannIntel topic hub on the Colorado cannabis market.
The next signal: any Marijuana Enforcement Division filing or Spherex statement naming the target and terms. We'll update this story when either surfaces.
Frequently asked questions
What did Spherex acquire in Colorado?
That isn't confirmed. Forbes reported the deal as Spherex's first acquisition and an expansion of its Colorado cannabis operations, but the target wasn't available in the initial signal CannIntel reviewed. We'll update when the company or state records identify it.
How much did Spherex pay for its first acquisition?
The price hasn't been disclosed in the information available to CannIntel. Neither the consideration type nor any earnout terms were included. We won't estimate a figure without a primary source.
Does a Colorado cannabis acquisition need state approval?
Ownership changes at licensed Colorado cannabis businesses typically involve review by the Marijuana Enforcement Division. Whether this deal required it, or has received it, isn't confirmed in the available reporting.
Why does a first acquisition matter for a cannabis company?
It shows a shift from organic growth to buying capacity. The acquirer must integrate licenses, staff, POS and inventory systems, and METRC reporting, which tests its operations and can quickly show up in margins.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business
MJBizDaily Reports Medical Cannabis Authorizers Up 16%
The growth in clinicians who can authorize medical cannabis could widen patient access, but operators only benefit if new authorizers actually certify patients.
Feature Flags Shelf-Life Testing Gap in THC Beverages
A testing expert says a production-day certificate of analysis doesn't guarantee the dose consumers get months later, sharpening the case for shared lab standards.
St. Louis jury awards $10M in Missouri cannabis ownership fight
A St. Louis jury put a $10 million price on a sprawling Missouri cannabis ownership dispute, and the full record is still thin.
More from the newsroom
Talking Joints Memo Revisits Portugal's 25 Years of Decriminalization
A 25-year retrospective on Portugal's 2001 drug law lands weeks before the US federal hemp redefinition, sharpening the gap between decriminalization and regulation.
Tennessee lawmakers weigh medical marijuana framework, AOL reports
Tennessee legislators are discussing the structure of a possible medical marijuana program, though public details on a bill, sponsor or vote remain thin.
Survey Names Age Group Most Likely to Drive After Cannabis Use
FOX 9 Minneapolis-St. Paul reported new survey data on which age range drives after cannabis use, putting impaired-driving enforcement back in front of regulators.